Seebio ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

   
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  21.3% 16.6% 16.4% 20.8% 14.8%  
Credit score (0-100)  5 10 10 4 13  
Credit rating  B BB BB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 7 0 0    
Gross profit  0.0 -2.1 -1.7 -21.0 -5.1  
EBITDA  0.0 -3.3 -5.3 -23.9 -10.4  
EBIT  0.0 -3.3 -5.3 -23.9 -10.4  
Pre-tax profit (PTP)  2.8 -0.4 -2.8 -1.9 -8.9  
Net earnings  2.1 -1.0 -2.8 -1.9 -8.9  
Pre-tax profit without non-rec. items  2.8 -0.4 -2.8 -1.9 -8.9  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  231 364 363 353 383  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  231 364 363 353 383  

Net Debt  -231 -364 -363 -353 -383  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 7 0 0 1  
Net sales growth  0.0% 0.0% -100.0% 0.0% 0.0%  
Gross profit  0.0 -2.1 -1.7 -21.0 -5.1  
Gross profit growth  0.0% 0.0% 21.1% -1,138.8% 75.6%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  231 364 363 353 383  
Balance sheet change%  35.3% 57.2% -0.1% -3.0% 8.7%  
Added value  0.0 -3.3 -5.3 -23.9 -10.4  
Added value %  0.0% -49.0% 0.0% 0.0% -1,674.8%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 -1.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% -49.0% 0.0% 0.0% -1,674.8%  
EBIT %  0.0% -49.0% 0.0% 0.0% -1,674.8%  
EBIT to gross profit (%)  0.0% 154.1% 311.3% 113.7% 203.6%  
Net Earnings %  0.0% -15.3% 0.0% 0.0% -1,426.0%  
Profit before depreciation and extraordinary items %  0.0% -15.3% 0.0% 0.0% -1,426.0%  
Pre tax profit less extraordinaries %  0.0% -5.8% 0.0% 0.0% -1,426.0%  
ROA %  1.4% -0.1% -0.8% -0.5% -2.4%  
ROI %  1.4% -0.1% -0.8% -0.5% -2.4%  
ROE %  1.1% -0.3% -0.8% -0.5% -2.4%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  100.0% 100.0% 100.0% 100.0% 100.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% -5,394.0% 0.0% 0.0% -61,517.8%  
Net int. bear. debt to EBITDA, %  0.0% 11,000.0% 6,888.2% 1,477.3% 3,673.1%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 0.0 0.0  
Current Ratio  0.0 0.0 0.0 0.0 0.0  
Cash and cash equivalent  231.4 363.8 363.3 352.5 383.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 5,394.0% 0.0% 0.0% 61,517.8%  
Net working capital  8.3 8.2 6.5 6.9 1.1  
Net working capital %  0.0% 121.7% 0.0% 0.0% 172.2%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0